A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Hepatocellular CarcinomaLiver CancerHCC
Interventions
BIOLOGICAL

JX-594 recombinant vaccina GM-CSF

Patients will be randomised 2:1 to Arm A or Arm B and will receive 6 treatments on days 1, 8, 22, week 6, week 12, and week 18 plus best supportive care as needed.

OTHER

Best Supportive Care

Patients will be randomised 2:1 to Arm A or Arm B and will receive best supportive care as needed.

Trial Locations (38)

20246

Universitätsklinikum Hamburg-Eppendorf, Hamburg

30625

Medizinische Hochschule Hannover, Hanover

31059

Hôpital Purpan, Toulouse

33000

Centre Hospitalier Universitaire Hôpital Saint André, Bordeaux

55131

Johannes Gutenberg-Universität Mainz, Mainz

63003

CHU d'Estaing, Clermont-Ferrand

67091

Hôpitaux Universitaires de Strasbourg - Hôpital Civil, Strasbourg

69317

Hôpital de la Croix Rousse, Lyon

75571

Hôpital Saint Antoine, CPP Ile de France V, Paris

77030

The Methodist Hospital Department of Surgery, Houston

81675

Klinikum Rechts der Isar der Technischen Universität München, München

92093

Moores University of California San Diego Cancer Center, La Jolla

92868

Chao Family Comprehensive Cancer Center, Orange

Unknown

California Pacific Medical Center, San Francisco

Stanford Hospital and Clinics, Stanford

University of Chicago Medical Center, Chicago

Billings Clinic, Billings

Saint Joseph's Hospital, Paterson

Montefiore Medical Center, The Bronx

Gabrail Cancer Center, Canton

University Hospitals Case Medical Center, Cleveland

University of British Columbia, Vancouver

Juravinski Cancer Centre, Hamilton

Ottawa Hopsital Research Institute, Ottawa

Queen Mary Hospital, Hong Kong

Kyungpook National University Hospital, Daegu

Pusan National University Hospital, Pusan

Korea University Guro Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Severance Hospital,Yonsei University Health System, Seoul

Pusan National University Yangsan Hospital, Yangsan

National Cheng-Kung University Hospital, Taipei

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei

T6G 2B7

University of Alberta, Edmonton

425-707

Korea University Ansan Hospital, Ansan-si

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Jennerex Biotherapeutics

INDUSTRY

NCT01387555 - A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib | Biotech Hunter | Biotech Hunter